AIDS/HIV Vaccine
Components of HIV vaccine are recognized by T-helper cells
Published in AIDS Weekly, May 17th, 2004
"HIV has thus far evaded control by vaccines, in part due to the high diversity among viral isolates. To effectively target HIV diversity, we propose that multi-envelope HIV vaccines should be designed. We hypothesize that minor components of complex envelope cocktail vaccines can be immunogenic and can thus elicit unique T-cell responses," researchers in the United States report.
"To test our hypothesis, we first defined unique T-helper cell determinants on 1007 (clade B) and UG92005 (UG, clade D) gp140 envelope proteins delivered by DNA vaccination,"...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2004-05-17)
More Articles from AIDS Weekly
- AIDS Therapy
FDA-approved study launched to treat AIDS patients in virologic failure - Endocrinology
Testosterone replacement improves muscle strength, function in HIV+ women - HIV/AIDS Epidemiology
HIV infection progresses to AIDS faster in developing countries - HIV/AIDS Therapy
HIV patients get long-term boost with short, intermittent drug regimen - HIV/AIDS Therapy
Non-protease drug combo better than others for fighting HIV - AIDS/HIV Genomics and Genetics
Wild-type CCR5 confers HIV-1 cross-clade resistance - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
